Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Are Antibody Tests Alone Enough to Detect HIV?

By LabMedica International staff writers
Posted on 30 Jun 2009
Antibody tests alone were insufficient to detect human immunodeficiency virus (HIV) in individuals.

Diagnosis of acute HIV infection relies on detection of HIV virus using viral load tests, or p24 antigen. More...
Pooled HIV viral load testing has been shown to be an effective means of diagnosing acute infections. However, it is slow, typically taking between 7 and 21 days to obtain the results, cumbersome, and laborious. It is, therefore, not a realistic technology for resource-limited settings, or for addressing the problem of ongoing transmission from people during acute infection.

The use of a test that combines rapid testing for HIV antibodies with an ultrasensitive p24 assay is an alternative. This should detect HIV infection several weeks earlier than previous generations of antibody tests in people recently infected. These fourth generation assays are now routinely used in some countries such as the United Kingdom.

Professor Susan H. Eshelman from the department of pathology, Johns Hopkins Medical Institutions (Baltimore, MD, USA), and colleagues used the Abbott (Abbott park, IL, USA) Architect HIV antigen/antibody (Ag/Ab) combo assay, to detect individuals with acute HIV-1 infection.

Testing for the antigen reduces the window period in which an individual might have been exposed to HIV and has a reactive test result. Thus, individuals exposed to HIV could test reactive for the antigen, but might not test reactive to the antibody. In this study, the Abbott combination assay detected 61.9 % of the acute infections whereas only 14.3 % of the acute samples were identified as positive by a third-generation antibody test. There were 21 acute infections among 217 samples from seronegative individuals.

The study was published online in the Journal of Acquired Immune Deficiency Syndromes (JAIDS), June 2009.

Related Links:
Johns Hopkins Medical Institutions
Abbott



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.